Christopher S. Hourigan

Also affiliated with Cancer Research Center, Biomedical Research Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 54 papers. Top paper: “Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia”.

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003392

N/A

2.1DataRank · unranked

77 citations

Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez +17 more

Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms

Blood Advances(2022)10.1182/bloodadvances.2022007936

N/A

1.4DataRank · unranked

58 citations

Ilker Tunc, Jason Hughes, Joseph Halstead, Allyson Mateja, Yihui Liu +40 more

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

Haematologica(2023)10.3324/haematol.2023.283520

N/A

1.1DataRank · unranked

35 citations

Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H. Smith +8 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations

Leukemia(2021)10.1038/s41375-021-01230-4

N/A

0.659DataRank · unranked

80 citations

Yishai Ofran, Agnieszka Wierzbowska, Farhad Ravandi, Christopher S. Hourigan, Lok Lam Ngai +5 more

Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2019001124

N/A

0.596DataRank · unranked

52 citations

Katherine E. Lindblad, Bogdan Popescu, Gege Gui, Meghali Goswami, Janet Valdez +15 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Blood Advances(2023)10.1182/bloodadvances.2023011308

N/A

0.483DataRank · unranked

24 citations

Mei‐Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly +64 more

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02447-4

N/A

0.480DataRank · unranked

10 citations

Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +18 more

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02449-2

N/A

0.480DataRank · unranked

10 citations

Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +18 more

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02444-7

N/A

0.306DataRank · unranked

6 citations

Georgia Andrew, Gege Gui, Niveditha Ravindra, Devdeep Mukherjee, Zoë C. Wong +15 more

Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia

medRxiv(2021)10.1101/2021.06.23.21258377

N/A

0.292DataRank · unranked

6 citations

Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez +17 more

Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia

medRxiv(2023)10.1101/2023.07.28.23293166

N/A

0.184DataRank · unranked

2 citations

Laura W. Dillon, Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee +17 more

Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS

Blood Neoplasia(2025)10.1016/j.bneo.2025.100106

N/A

0.165DataRank · unranked

2 citations

Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W. Dillon +11 more

Pre-MEASURE: FLT3 -ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission

medRxiv(2022)10.1101/2022.10.21.22281322

N/A

0.126DataRank · unranked

1 citations

Gege Gui, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew, Devdeep Mukherjee +16 more

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

0DataRank · unranked

373 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

Leukemia(2022)10.1038/s41375-022-01738-3

N/A

0DataRank · unranked

21 citations

Mei‐Jie Zhang, Karen Chen, Hisham Abdel‐Azim, Muhammad Bilal Abid, Mahmoud Aljurf +47 more

Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms

Leukemia(2022)10.1038/s41375-022-01797-6

N/A

0DataRank · unranked

10 citations

Eddie L. Imada, Sergiu Paşca, Shiyu Wang, Hang Chen, Camille Alba +10 more

Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia

The Cancer Journal(2022)10.1097/ppo.0000000000000572

N/A

0DataRank · unranked

13 citations

Christopher S. Hourigan, Gege Gui

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.018

N/A

0DataRank · unranked

7 citations

Madison Reed, Hua‐Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern +25 more

Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms

medRxiv(2022)10.1101/2022.04.29.22274379

N/A

0DataRank · unranked

2 citations

Ilker Tunc, Jason D. Hughes, Joseph Halstead, Allyson Mateja, Yihui Liu +40 more

How I Treat AML in 2023 Incorporating the Updated Classifications and Guidelines

Blood(2023)10.1182/blood.2022017808

N/A

0DataRank · unranked

47 citations

Christopher S. Hourigan, Amer M. Zeidan, Firas El Chaer

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel

American Journal of Hematology(2023)10.1002/ajh.27087

N/A

0DataRank · unranked

24 citations

Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman +12 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia

Best Practice & Research Clinical Haematology(2023)10.1016/j.beha.2023.101468

N/A

0DataRank · unranked

10 citations

Laura W. Dillon, Christopher S. Hourigan, Zoë C. Wong

Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia

Acta Haematologica(2023)10.1159/000535463

N/A

0DataRank · unranked

6 citations

Christopher S. Hourigan, Amanda Blackmon

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

medRxiv(2023)10.1101/2023.03.26.23287367

N/A

0DataRank · unranked

8 citations

Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H. Smith +8 more

Persistent IDH mutations are not associated with increased relapse or death in patients with IDH -mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide

medRxiv(2023)10.1101/2023.08.14.23294087

N/A

0DataRank · unranked

1 citations

Laura W. Dillon, Gege Gui, Matthew Smith, Lukasz P. Gondek, Richard J. Jones +4 more

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

JAMA Oncology(2024)10.1001/jamaoncol.2024.0985

N/A

0DataRank · unranked

54 citations

Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +20 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance

Leukemia(2024)10.1038/s41375-024-02300-z

N/A

0DataRank · unranked

16 citations

Gege Gui, Florent Dumézy, Christophe Roumier, Georgia Andrew, Sarah Green +8 more

Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis

Cytometry Part B Clinical Cytometry(2024)10.1002/cyto.b.22174

N/A

0DataRank · unranked

6 citations

Xiaoping Sun, Dragan Maric, Sachein Sharma, Hirsh D. Komarow, Christopher S. Hourigan +3 more

TP53 mutation screening for patients at risk of myeloid malignancy

medRxiv(2024)10.1101/2024.02.06.24302401

N/A

0DataRank · unranked

0 citations

Rialnat A. Lawal, Courtney D. Fitzhugh, Christopher S. Hourigan, Laura W. Dillon, Devdeep Mukherjee

Pre-emptive Detection and Evolution of Relapse in Acute Myeloid Leukemia by Flow Cytometric Measurable Residual Disease Surveillance

Research Square(2024)10.21203/rs.3.rs-3978470/v1

N/A

0DataRank · unranked

0 citations

Nicholas McCarthy, Gege Gui, Florent Dumézy, Christophe Roumier, Georgia Andrew +8 more

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2025)10.1038/s41409-025-02757-1

N/A

0DataRank · unranked

2 citations

Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +23 more

Role of MRD testing in acute myeloid leukemias. What is the status and how to get there?

Seminars in Hematology(2025)10.1053/j.seminhematol.2026.03.009

N/A

0DataRank · unranked

2 citations

Christopher S. Hourigan

Overall survival, conditioning, and MRD in MORPHO

Blood Advances(2025)10.1182/bloodadvances.2025017937

N/A

0DataRank · unranked

1 citations

Christopher S. Hourigan, Gege Gui

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

New England Journal of Medicine(2020)10.1056/nejmoa2026834

N/A

0DataRank · unranked

1168 citations

Marcela A. Ferrada, Keith A. Sikora, Amanda K. Ombrello, Jason C. Collins, Wuhong Pei +57 more

Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AML

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.24.634753

N/A

0DataRank · unranked

2 citations

Molly A. Bingham, Julius Raimund Herzog, Abigail Wong-Rolle, Laura W. Dillon, Meghali Goswami +13 more

Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

JAMA Oncology(2020)10.1001/jamaoncol.2020.4600

N/A

0DataRank · unranked

373 citations

Shouhao Zhou, Chenqi Fu, Donald A. Berry, Roland B. Walter, Sylvie Freeman +8 more

Baseline TP53 mutations in Adults with SCD developing Myeloid Malignancy following Hematopoietic Cell Transplantation

Blood(2020)10.1182/blood.2019004001

N/A

0DataRank · unranked

65 citations

Xin Xu, Irina Marić, Laura W. Dillon, Yuesheng Li, Matthew M. Hsieh +3 more

Detectable mutations precede late myeloid neoplasia in aplastic anemia

Haematologica(2020)10.3324/haematol.2020.263046

N/A

0DataRank · unranked

15 citations

Jack Ghannam, Emma M. Groarke, Meghali Goswami, Laura W. Dillon, Fernanda Gutierrez‐Rodrigues +6 more

Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis

medRxiv(2020)10.1101/2020.10.22.20216028

N/A

0DataRank · unranked

5 citations

Jack Ghannam, Chidera Nosiri, Gege Gui, Meghali Goswami, Katherine R. Calvo +22 more

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Blood(2021)10.1182/blood.2021013626

N/A

0DataRank · unranked

738 citations

Sylvie Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai +40 more

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004916

N/A

0DataRank · unranked

77 citations

Leland Metheny, Mei‐Jie Zhang, Hailin Wang, Noel Estrada‐Merly, David I. Marks +72 more

Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Nonmalignant Clonal Hematopoiesis

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0046

N/A

0DataRank · unranked

41 citations

Jack Ghannam, Chidera Nosiri, Gege Gui, Meghali Goswami, Katherine R. Calvo +22 more

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.010

N/A

0DataRank · unranked

29 citations

Natalie S. Callander, Aric C. Hall, Mei-Jei Zhang, Khalid Bo-Subait, Hailin Wang +43 more

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Bone Marrow Transplantation(2021)10.1038/s41409-021-01450-3

N/A

0DataRank · unranked

27 citations

Marcos de Lima, Krishna V. Komanduri, Trent Wang, Mei-Jie Zhang, Karen Chen +56 more

Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

JCO Precision Oncology(2021)10.1200/po.20.00355

N/A

0DataRank · unranked

25 citations

Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li +17 more

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Blood Advances(2021)10.1182/bloodadvances.2021004881

N/A

0DataRank · unranked

13 citations

Alexandra Gomez-Arteaga, Rafael Madero‐Marroquin, Mei‐Jie Zhang, Khalid Bo-Subait, J. Ortiz Sánchez +51 more

Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML

Blood Advances(2021)10.1182/bloodadvances.2020003839

N/A

0DataRank · unranked

9 citations

Uma Borate, Rémy Duléry, Shernan G. Holtan, Arjun Law, Lori Muffly +8 more

Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis

Haematologica(2021)10.3324/haematol.2021.279230

N/A

0DataRank · unranked

9 citations

Isabel Beerman, Emma M. Groarke, Bhavisha A. Patel, Nina Spitofsky, Laura W. Dillon +6 more

250 Spatial-transcriptomic analysis of tumor-immune microenvironment in AML patients receiving pembrolizumab and decitabine

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.250

N/A

0DataRank · unranked

2 citations

Abigail Wong-Rolle, Prajan Divakar, Katherine R. Calvo, Christopher S. Hourigan, Chen Zhao